Cutaneous leishmaniasis of the lid: a report of nine cases.
Leishmaniasis is a parasitic disease caused by Leishmania species and is classified into three forms; cutaneous, mucocutaneous, and visceral. The eyelid is a rare site involved by leishmaniasis and only makes up 2.5% of cases with cutaneous leishmaniasis (CL). Although CL can affect both upper and lower lids on either their outer or inner aspects, the lateral canthus is most often affected. The most common aspect of lid leishmaniasis is chalazion-like lesions but ulcerous, phagedenic, cancer-like forms, and unilateral chronic granulomatous blepharitis may be observed. When the lid is involved, the disease is usually self-limiting; healing usually takes up to one year, hence early diagnosis and treatment are important. The diagnosis is based on a high index of suspicion regarding the endemicity of the disease in the region. Response to treatment in lid CL cases is quite satisfactory. In this article, we report nine cases of lid leishmaniasis with satisfactory responses to intralesional meglumine antimoniate.
Yaghoobi
Reza
R
Department of Dermatology, Research Center of Thalassemia and Hemoglobinopathy, Jondi Shapour University of Medical Sciences, Ahwaz, Iran. yaghoobi_rz@yahoo.com
Maraghi
Sharif
S
Bagherani
Nooshin
N
Rafiei
Abdolla
A
D000293:Adolescent; D000328:Adult; D002648:Child; D005141:Eyelid Diseases / Q000469:parasitology*; D005143:Eyelids / Q000469:parasitology*; D005260:Female; D006801:Humans; D007223:Infant; D015552:Injections, Intralesional; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008297:Male; D008536:Meglumine / Q000008:administration & dosage*; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000008:administration & dosage*; D016896:Treatment Outcome
D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate